2025 annual financial data
BioRestorative Therapies 2025 Operating margin
Direct answer
Operating margin was -4,350.05%.
Operating income was -15,647,132 USD and net income was -14,241,975 USD.
Operating cash flow was -10,788,963 USD.
Get free BioRestorative Therapies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 359,700 USD
- Operating income
- -15,647,132 USD
- Net income
- -14,241,975 USD
- Operating cash flow
- -10,788,963 USD